Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French society of pediatric hematology and immunology (SHIP)

Bone Marrow Transplantation

Volumn 17, Issue 2, 1996, Pages 191-196

  Michel, G ^a   Leverger, G ^b   Leblanc, T ^c   Nelken, B ^d   Baruchel, A ^c   Landman Parker, J ^b   Thuret, I ^a   Bergeron, C ^e   Bordigoni, P ^f   Esperou Bourdeau, H ^c   Perel, Y ^g   Vannier, J P ^h   Schaison, G ^c  

^a TIMONE HOSPITAL   (France)

^b ARMAND TROUSSEAU HOSPITAL   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e SERVICE DE RHUMATOLOGIE   (France)

^f Hopital d'Enfants   (Morocco)

^g Hôpital d'Enfants de Bordeaux   (France)

^h HÔPITAL CHARLES NICOLLE   (France)

Author keywords

BMT; Chemotherapy; Childhood AML

Indexed keywords

AMSACRINE; ASPARAGINASE; CYTARABINE; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; DEATH; FEMALE; HLA MATCHING; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; RELAPSE; RISK; SIBLING; SURVIVAL;

AMSACRINE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYTARABINE; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY; HUMANS; INFANT; LEUKEMIA, MYELOID; LIFE TABLES; MALE; MITOXANTRONE; NUCLEAR FAMILY; PROGNOSIS; PROSPECTIVE STUDIES; REMISSION INDUCTION; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0030041081     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Dinsmore R, Kirkpatrick D, Flomenberg N et al. Allogeneic bone marrow transplantation for patient with acute nonlymphocytic leukemia. Blood 1984; 63: 649-656.
2. Brochstein JA, Kernan NA, Groshen S et al. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia. New Engl J Med 1987; 317: 1618-1624.
3. Sanders JE, Thomas ED, Buckner CD et al. Marrow transplantation for children in first remission of acute nonlymphoblastic leukemia: an update. Blood 1985; 66: 460-462.
4. Bostrom B, Brunning RD, McGlave P et al. Bone marrow transplantation for acute nonlymphoblasdc leukemia in first remission: analysis of prognostic factors. Blood 1985; 65: 1191-1196.
5. Feig SA, Nesbit ME, Buckley J et al. Bone marrow transplantation for acute non-lymphocytic leukemia: a report from the Childrens Cancer Study Group of 67 children transplanted in first remission. Bone Marrow Transplant 1987; 2: 365-374.
6. Dini G, Abla O, Uderzo C et al. Allogeneic bone marrow transplantation in children with ANLL: Italian experience. Bone Marrow Transplant 1991; 7 (suppl. 3): 76-79.
7. Forman AJ, Krance RA, O'Donnell MR et al Bone marrow transplantation for acute nonlymphoblastic leukemia during first complete remission. Transplantation 1987; 43: 650-653.
8. Amadori S, Testi AM, Arico M et al. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogeneous leukemia. J Clin Oncol 1993; 11: 1046-1054.
9. Nesbit ME, Buckley JD, Feig SA et al. Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group. J Clin Oncol 1994; 12: 127-135.
10. Dahl GV, Kalwinski DK, Mirro J et al. Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission. J Clin Oncol 1990; 8: 295-303.
11. Wells RJ, Woods WG, Buckley JD et al. Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: a Childrens Cancer Group study. J Clin Oncol 1994; 12: 2367-2377.
12. Wells RJ, Woods WG, Lampkin BC et al. Impact of high-dose cytarabine and asparaginase intensification on childhood acute myeloid leukemia: a report from the Childrens Cancer Group. J Clin Oncol 1993; 11: 538-545.
13. Michel G, Gluckman E, Biaise D et al. Improvement in outcome for children receiving allogeneic bone marrow transplantation in first complete remission of acute myeloid leukemia. A report from the GEGMO. J Clin Oncol 1992; 10: 1865-1869.
14. Copeland EA, Biggs JC, Thompson JM et al. Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2. Blood 1991; 78: 838-843.
15. Santos GW, Tutschka PJ, Brookmeyer R et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulphan and cyclophosphamide. New Engl J Med 1983; 309: 1347-1353.
16. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
17. Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man: a long-term clinico-pathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
18. Schwartz D (ed). Methodes statistiques à l'usage des médecins et des biologistes. Flammarion Med Sci, Paris, 1969.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
20. Clift R, Goldman JM, Graftwohl A, Horowitz M. Proposals for standardized reporting of results of bone marrow transplantation for leukemia. Bone Marrow Transplant 1989; 4: 445-448.
21. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
22. Cox DR. Regression models and life tables. JR Stat Soc 1972; 34: 187-202.
23. Woods WG, Ruymann FB, Lampkin BC et al. The role of timing of high-dose cytosine arabinosine intensification and of maintenance therapy in the treatment of children with acute nonlymphoblastic leukemia. Cancer 1990; 66: 1106-1113.
24. Feig SA, Lampkin B, Nesbit ME et al. Outcome of BMT during first complete remission of AML: a comparison of two sequential studies by the Childrens Cancer Group. Bone Marron Transplant 1993; 12: 65-71.
25. Woods WG, Kobrinsky N, Buckley J et al. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study. J Clin Oncol 1993; 11: 1448-1457.